Category: Brief Report

These are empirical analyses with a more narrow focus than original research articles and generally a single aim.

ISPOR PUBLISHES TASK FORCE REPORT #2 ON MULTIPLE CRITERIA DECISION ANALYSIS

Second Report Published in March/April Issue of Value in Health Princeton, NJ—April 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report

Posted in Announcements, Brief Report, ISPOR News & Press, Value in Health Tagged with: , , , , , , , , , , , ,

ISPOR PUBLISHES NEW GLOBAL HEALTH CARE SYSTEMS ROAD MAP FOR DENMARK PHARMACEUTICALS

Princeton, NJ—January 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today that it has published a new Global Health Care Systems Road Map—Denmark Pharmaceuticals. 

Posted in Announcements, Brief Report, ISPOR News & Press Tagged with: , , , , , ,

Older Adults with Mild Cognitive Impairment Can Reliably Express Their Preferences for Health Care Using Discrete Choice Experiments

Adelaide, South Australia – Researchers from Flinders University found that mild cognitive impairment did not affect the ability of older adults to reliably respond to questions about their preferred rehabilitation services following hip fracture.

Posted in Brief Report, Value in Health Tagged with: , , ,

Estimation Of Potential Gain In Quality Of Life From Early Detection Of Cervical Cancer

Tainan, Taiwan – Each year, about 528,000 new cases of cervical cancer are reported worldwide. In Taiwan, a screening program exists for early detection, which can save life-years for those individuals who are affected, but the effect on quality of life still

Posted in Brief Report, Value in Health Tagged with: , , , ,

How to Measure Preferences Over Health Care Options?

Chicago, IL, USA – Allocation of resources across health care delivery modes is arguably as important as allocation of resources across diseases. For example, given a disease state such as advanced cancer, patients may experience significantly different quality of life (QOL) depending

Posted in Brief Report, Value in Health Tagged with: , , , ,

Valuing Rare Disease Medicines – We Can Do Better

London, United Kingdom – Many rare diseases, often severe and life-threatening, cannot be treated. The small numbers of patients affected make it time-consuming and costly to compile evidence about treatments. Organisations that pay for health care recognise that a special approach

Posted in Brief Report, Value in Health Tagged with: , , , ,